Clinical Trials Directory

Trials / Completed

CompletedNCT02051530

Mood, Serotonin and Social Interaction

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Groningen · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Rationale: Major depressive disorder (MDD) is a psychiatric disorder whose onset, severity, and duration are influenced by interpersonal factors. The serotonin system is known to influence MDD risk. Recent research has suggested that serotonin may also play a role in regulating social behaviour. Therefore, it would be interesting to study the role of serotonin in responses to social stimuli in individuals at risk for MDD. Objective: This project aims to study how changes in serotonin alter interpersonal functioning in adults with or without a first degree family member diagnosed with MDD. The primary goal is to investigate the effect of experimentally lowered brain serotonin levels on empathic accuracy. Secondary goals are to determine how this manipulation influences verbal and non-verbal communication, cardiovascular function in a social context, and mood. An exploratory goal is to investigate how these outcomes are related to genes thought to be involved in MDD.

Detailed description

see summary

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTtryptophan depletiontryptophan depletion involves the ingestion of an amino acid mixture that is devoid of tryptophan. on the other day participants receive placebo, being the same mixture but including tryptophan

Timeline

Start date
2012-04-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2014-01-31
Last updated
2015-01-30

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02051530. Inclusion in this directory is not an endorsement.